Rothschild Investment LLC’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.31K | Buy |
150
+15
| +11% | +$431 | ﹤0.01% | 1588 |
|
|
2025
Q1 | $4.53K | Buy |
135
+35
| +35% | +$1.17K | ﹤0.01% | 1485 |
|
|
2024
Q4 | $5.11K | Buy |
100
+15
| +18% | +$767 | ﹤0.01% | 1339 |
|
|
2024
Q3 | $4.34K | Buy |
85
+55
| +183% | +$2.81K | ﹤0.01% | 1353 |
|
|
2024
Q2 | $1.34K | Buy |
30
+25
| +500% | +$1.12K | ﹤0.01% | 1523 |
|
|
2024
Q1 | $234 | Buy |
+5
| New | +$234 | ﹤0.01% | 1676 |
|